1435049 - Aduro Biotech, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ADRO (1435049)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S9-1-1-6+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-11-17
ADROTempleman BlaineEVP, GCS - Sale$8.85-24358,8340%-$2,151
D
2017-11-15
ADROLew JenniferSVP of FinanceM - OptEx$0.82+6,60062,338+12%+$5,412
D
2017-11-15
ADROLew JenniferSVP of FinanceS - Sale+OE$8.95-6,60062,338-10%-$59,070
DM
2017-11-10
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+19,800244,578+9%+$8,910
DM
2017-11-10
ADROIsaacs Stephen TPres, CEOS - Sale+OE$7.97-19,800244,578-7%-$157,723
DM
2017-11-10
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+5,87773,718+9%+$3,056
DM
2017-11-10
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$8.00-5,87773,718-7%-$47,040
D
2017-11-06
ADROSchafer Gregory WCOOM - OptEx$1.04+20,000148,745+16%+$20,767
D
2017-11-06
ADROSchafer Gregory WCOOS - Sale+OE$7.97-20,000148,745-12%-$159,312
D
2017-11-06
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+4,12373,718+6%+$2,144
D
2017-11-06
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$8.04-4,12373,718-5%-$33,132
DM
2017-11-06
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+20,200244,578+9%+$9,090
DM
2017-11-06
ADROIsaacs Stephen TPres, CEOS - Sale+OE$7.98-20,200244,578-8%-$161,157
D
2017-10-02
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+10,00073,718+16%+$5,200
D
2017-10-02
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$10.59-10,00073,718-12%-$105,870
D
2017-10-02
ADROSchafer Gregory WCOOM - OptEx$1.36+20,000148,745+16%+$27,148
D
2017-10-02
ADROSchafer Gregory WCOOS - Sale+OE$10.75-20,000148,745-12%-$215,060
D
2017-10-02
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+40,000244,578+20%+$18,000
D
2017-10-02
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.78-40,000244,578-14%-$431,032
D
2017-10-02
ADROLew JenniferSVP of FinanceM - OptEx$0.82+6,60062,338+12%+$5,412
D
2017-10-02
ADROLew JenniferSVP of FinanceS - Sale+OE$10.61-6,60062,338-10%-$69,995
2017-09-18
ADROTempleman BlaineEVP, GCS - Sale$11.20-2,88458,834-5%-$32,301
2017-09-12
ADROIsaacs Stephen TPres, CEOA - Grant$0.00+82,100244,578+51%+$0
2017-09-13
ADROIsaacs Stephen TPres, CEOS - Sale$10.99-12,204244,578-5%-$134,071
2017-09-12
ADROSchafer Gregory WCOOA - Grant$0.00+32,625148,745+28%+$0
2017-09-13
ADROSchafer Gregory WCOOS - Sale$10.99-4,859148,745-3%-$53,380
2017-09-12
ADROSacks NatalieChief Medical OfficerA - Grant$0.00+32,62577,740+72%+$0
2017-09-12
ADROBrockstedt Dirk G.EVP of Research, Dev.A - Grant$0.00+27,97573,718+61%+$0
2017-09-13
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale$10.99-3,55773,718-5%-$39,076
2017-09-12
ADROLew JenniferSVP of FinanceA - Grant$0.00+23,30062,338+60%+$0
2017-09-13
ADROLew JenniferSVP of FinanceS - Sale$10.99-3,55762,338-5%-$39,076
2017-09-12
ADROVan Elsas AndreaChief Scientific OfficerA - Grant$0.00+32,625207,231+19%+$0
2017-09-13
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$10.99-4,922207,231-2%-$54,072
2017-09-12
ADROTempleman BlaineEVP, GCA - Grant$0.00+27,97561,718+83%+$0
2017-09-13
ADROTempleman BlaineEVP, GCS - Sale$10.99-3,55761,718-5%-$39,076
2017-09-01
ADROSacks NatalieChief Medical OfficerS - Sale$11.71-4,88545,115-10%-$57,196
D
2017-09-01
ADROSchafer Gregory WCOOM - OptEx$1.24+20,000120,979+20%+$24,800
D
2017-09-01
ADROSchafer Gregory WCOOS - Sale+OE$11.70-20,000120,979-14%-$233,980
D
2017-09-01
ADROLew JenniferSVP of FinanceM - OptEx$0.82+6,60042,595+18%+$5,412
D
2017-09-01
ADROLew JenniferSVP of FinanceS - Sale+OE$11.70-6,60042,595-13%-$77,242
D
2017-09-01
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+40,000174,682+30%+$18,000
D
2017-09-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.71-40,000174,682-19%-$468,596
D
2017-09-01
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+10,00049,300+25%+$5,200
D
2017-09-01
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.69-10,00049,300-17%-$116,948
DM
2017-08-10
ADRODubensky Thomas W.Chief Scientific OfficerM - OptEx$1.00+50,00039,900-495%+$50,000
DM
2017-08-10
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.38-50,00039,900-56%-$569,203
D
2017-08-07
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+40,000174,682+30%+$18,000
D
2017-08-07
ADROIsaacs Stephen TPres, CEOS - Sale+OE$12.19-40,000174,682-19%-$487,564
DM
2017-08-07
ADROSchafer Gregory WCOOM - OptEx$1.24+40,000120,979+49%+$49,620
DM
2017-08-07
ADROSchafer Gregory WCOOS - Sale+OE$12.17-40,000120,979-25%-$486,783
D
2017-08-07
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+10,00049,300+25%+$5,200
D
2017-08-07
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$12.18-10,00049,300-17%-$121,795
D
2017-08-07
ADROLew JenniferSVP of FinanceM - OptEx$0.82+6,60042,595+18%+$5,412
D
2017-08-07
ADROLew JenniferSVP of FinanceS - Sale+OE$12.17-6,60042,595-13%-$80,290
D
2017-07-03
ADROLew JenniferSVP of FinanceM - OptEx$0.82+12,00042,595+39%+$9,840
D
2017-07-03
ADROLew JenniferSVP of FinanceS - Sale+OE$11.14-12,00042,595-22%-$133,632
D
2017-07-03
ADROIsaacs Stephen TPres, CEOM - OptEx$0.50+40,000174,682+30%+$19,965
DM
2017-07-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.06-40,000174,682-19%-$442,397
D
2017-07-03
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.48+10,00049,300+25%+$4,826
D
2017-07-03
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.02-10,00049,300-17%-$110,167
DM
2017-07-03
ADRODubensky Thomas W.Chief Scientific OfficerM - OptEx$0.52+50,00039,900-495%+$26,000
DM
2017-07-03
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.33-50,00039,900-56%-$566,638
D
2017-06-28
ADROLew JenniferSVP of FinanceM - OptEx$0.82+12,00042,595+39%+$9,840
D
2017-06-28
ADROLew JenniferSVP of FinanceS - Sale+OE$11.19-12,00042,595-22%-$134,236
D
2017-06-28
ADROSchafer Gregory WCOOM - OptEx$1.45+40,000120,979+49%+$58,000
D
2017-06-28
ADROSchafer Gregory WCOOS - Sale+OE$11.26-40,000120,979-25%-$450,568
D
2017-06-19
ADROIsaacs Stephen TPres, CEOM - OptEx$0.52+40,000174,682+30%+$20,800
D
2017-06-19
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.50-40,000174,682-19%-$420,164
DM
2017-06-01
ADRODubensky Thomas W.Chief Scientific OfficerM - OptEx$0.52+144,30139,900-138%+$75,037
DM
2017-06-01
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$10.03-144,30139,900-78%-$1,447,777
D
2017-06-01
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+8,00049,300+19%+$4,160
D
2017-06-01
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$10.00-8,00049,300-14%-$80,020
2017-05-17
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale$9.65-1,01149,300-2%-$9,756
2017-05-17
ADROTempleman BlaineEVP, GCS - Sale$9.65-1,64837,300-4%-$15,903
DM
2017-05-15
ADROIsaacs Stephen TPres, CEOM - OptEx$0.52+27,273174,682+19%+$14,182
DM
2017-05-15
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.01-27,273174,682-14%-$272,950
D
2017-05-11
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+8,00049,300+19%+$4,160
D
2017-05-11
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$9.72-8,00049,300-14%-$77,725
DM
2017-05-11
ADRODubensky Thomas W.Chief Scientific OfficerM - OptEx$0.52+5,69939,900+17%+$2,963
DM
2017-05-11
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$9.92-5,69939,900-12%-$56,528
D
2017-04-03
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.45+8,00049,300+19%+$3,600-3-3+6
D
2017-04-03
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$10.71-8,00049,300-14%-$85,645-3-3+6
D
2017-04-03
ADROIsaacs Stephen TPres, CEOM - OptEx$0.52+27,273172,857+19%+$14,182-3-3+6
D
2017-04-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.28-27,273172,857-14%-$280,429-3-3+6
D
2017-03-13
ADROIsaacs Stephen TPres, CEOM - OptEx$0.52+27,273172,857+19%+$14,182+3+5-14
D
2017-03-13
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.35-27,273172,857-14%-$309,434+3+5-14
D
2017-03-09
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.45+8,00049,300+19%+$3,60000-23
D
2017-03-09
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.00-8,00049,300-14%-$88,00100-23
D
2017-03-09
ADRODubensky Thomas W.Chief Scientific OfficerM - OptEx$0.78+25,00039,900+168%+$19,44600-23
D
2017-03-09
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$10.96-25,00039,900-39%-$274,07800-23
D
2017-01-17
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.45+8,00049,300+19%+$3,600+1+1+4
D
2017-01-17
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.86-8,00049,300-14%-$94,858+1+1+4
2017-01-11
ADROTempleman BlaineEVP, GCS - Sale$11.95-3,78537,300-9%-$45,231-4-10-13
D
2017-01-03
ADRODubensky Thomas W.Chief Scientific OfficerM - OptEx$0.52+25,00039,900+168%+$13,000-2-10
D
2017-01-03
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.16-25,00039,900-39%-$278,990-2-10
D
2017-01-03
ADROIsaacs Stephen TPres, CEOM - OptEx$0.52+27,273172,857+19%+$14,182-2-10
D
2017-01-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.12-27,273172,857-14%-$303,289-2-10
D
2016-12-23
ADROSchafer Gregory WCOOM - OptEx$0.82+35,000120,979+41%+$28,700+2+30
2016-12-15
ADROIsaacs Stephen TPres, CEOG - Gift$0.00-51,000172,857-23%-$0-4-10+2
D
2016-12-01
ADROIsaacs Stephen TPres, CEOM - OptEx$0.52+27,273223,857+14%+$14,182+4+2+4

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top